Author:
Chai San Bao,Li Xue Min,Pang Yong Zheng,Qi Yong Fen,Tang Chao Shu
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference27 articles.
1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui T, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
2. Sutherland AJ, Nataatmadja MI, Walker PJ, Cutte L, Garlick RB, West MJ (2006) Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression. Circulation 113:1180–1188
3. Bern HA, Pearson D, Larson BA, Nishioka RS (1985) Neurohormones from fish tails: the caudal neurosecretory system. I. “Urophysiology” and the caudal neurosecretory system of fishes. Recent Prog Horm Res 41:533–552
4. Douglas SA, Ohlstein EH (2000) Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 10:229–237
5. Maguire JJ, Kuc RE, Wiley KE, Kleinz MJ, Davenport AP (2004) Cellular distribution of immunoreactive urotensin-II in human tissue with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries. Peptides 25:1767–1774
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献